Clinical trial
Discovery of Genetic Variants Contributing to the Incidence or Course of CMV Disease in AIDS Patients
NCT00341172 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Discovery of Genetic Variants Contributing to the Incidence or Course of CMV Disease in AIDS Patients
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 26, 2004
- Completion date
- March 4, 2021
- Enrollment
- 2,232 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aids